A study showing that the anti-malaria drug touted by President Trump, hydroxychloroquine, harmed COVID-19 patients is likely based on fabricated data.
An investigation by the Guardian found that the study, published in the Lancet (a prestigious medical journal), relied on data from a company called Surgisphere that appears to be highly suspect. The Lancet released an “expression of concern” about the study during the investigation.
Real journalism.Trusted by millions.
Unlimited access to in-depth reporting, expert analysis, and the stories that shape our country.
Subscribe Now
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.